Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,419.90 -160.83 -1.28%
S&P 500 1,313.32 -19.10 -1.43%
Nasdaq 2,837.36 -33.63 -1.17%
Ticker Volume Price Price Delta
STOXX 50 2,129.67 +13.49 0.64%
FTSE 100 5,340.12 +42.84 0.81%
DAX 6,305.69 +24.89 0.40%
Ticker Volume Price Price Delta
Nikkei 8,542.73 -90.46 -1.05%
TOPIX 719.49 -4.13 -0.57%
Hang Seng 18,629.50 -60.70 -0.32%
Gold 1,562.90 -0.18%
EUR-USD 1.2405 0.3089%
Nasdaq 2,837.36 -1.17%
DJIA 12,419.90 -1.28%
S&P 500 1,313.32 -1.43%
FTSE 100 5,340.12 +0.81%
STOXX 50 2,129.67 +0.64%
DAX 6,305.69 +0.40%
Oil (WTI) 87.89 +0.08%
U.S. 10-year 1.610% -0.012
BAC:US 7.20 -3.23%
FB:US 28.19 -2.25%

Archer Raises A$1.5 Billion for Fifth Australian Private Equity Fund

Archer Capital, the Australian private-equity firm formed in 1996, raised A$1.5 billion ($1.5 billion) from local and international investors for its fifth fund.

Archer, which has invested more than A$600 million this year, announced plans to raise the money in September, the company said today in an emailed statement.

Sydney-based Archer this year made investments in companies including private hospital operator Healthe Care Australia, the Red Rooster and Oporto fast-food chains, and bought a controlling stake in V8 Supercars.

The firm also sold assets, including the sale of financial software company MYOB Pty Ltd. to Bain Capital LLC and iNova Pharmaceuticals (Australia) Pty to Valeant Pharmaceuticals International Inc. of the U.S. This year’s divestitures totaled more than A$2.5 billion and returned 3.2 times the initial investment, Archer said in the statement.

To contact the reporter on this story: Brett Foley in Melbourne at bfoley8@bloomberg.net

To contact the editor responsible for this story: Philip Lagerkranser at lagerkranser@bloomberg.net

Sponsored Links